Showing results (321-330 of 457) with videos related to
Sort By:
Pageof 46
Journal of Agricultural and Food Chemistry|October 25, 2023
Perspectives on Nasal Odorant Metabolism ResearchNicole Kornbausch, Jeanne Mérignac-Lacombe, Fabrice Neiers, et al.Rheumatology (Oxford, England)|August 1, 2023
Proteomics analyses of human plasma reveal triosephosphate isomerase as a potential blood marker of methotrexate resistance in rheumatoid arthritisJean Escal, Tiphany Neel, Sophie Hodin, et al.Chemical Senses|July 8, 2008
Relationships between molecular structure and perceived odor quality of ligands for a human olfactory receptorGuenhaël Sanz, Thierry Thomas-Danguin, El Hassan Hamdani, et al.Bone|September 21, 2021
Romosozumab reduces incidence of new vertebral fractures across severity grades among postmenopausal women with osteoporosisPiet Geusens, Robert Feldman, Mary Oates, et al.Fundamental & Clinical Pharmacology|January 3, 2025
Long-term evaluation of rheumatoid arthritis activity with erythrocyte methotrexate-polyglutamate 3Jean Escal, Marion Poudret, Sophie Hodin, et al.European Journal of Endocrinology|February 1, 2014
THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal womenApostolos Gogakos, John G Logan, Julian A Waung, et al.Rheumatology (Oxford, England)|May 26, 2020
Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse eventsSoledad Henriquez, Bertrand Dunogué, Raphael Porcher, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 31, 2009
Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone densityHenry G Bone, Michael R McClung, Christian Roux, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 7, 2017
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its ExtensionSteven R Cummings, Serge Ferrari, Richard Eastell, et al.JBMR Plus|May 22, 2026
Rare disease care pathways profile in France: leveraging hospital big data to characterize natural history in osteogenesis imperfectaJulia Herrou, Nathanael Beeker, Valerie Cormier Daire, et al.Pageof 46